Exact Mass: 381.02418159999996
Exact Mass Matches: 381.02418159999996
Found 63 metabolites which its exact mass value is equals to given mass value 381.02418159999996
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one
Desacetycefapirin
Desacetycefapirin is a potential milk contaminant arising from the metabolism of cefapirin in cattle. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams Potential milk contaminant arising from the metabolism of cefapirin in cattle
5'-Carboxy meloxicam
5-Carboxy meloxicam is a metabolite of meloxicam. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is a derivative of oxicam, closely related to piroxicam, and falls in the enolic acid group of NSAIDs. It was developed by Boehringer-Ingelheim. (Wikipedia)
N-Acetylgalactosamine 4,6-disulfate
C8H15NO12S2 (381.00356700000003)
N-Acetylgalactosamine 4,6-disulfate (GalNAc4,6diS) is one of the sulphated N-acetylhexosamines that have been isolated from human urine. PMID: 3931626. N-Acetylgalactosamine 4,6-disulfate (GalNAc4,6diS)is one of the sulphated N-acetylhexosamines that have been isolated from human urine.
dehydrofelodipine
C18H17Cl2NO4 (381.0534582000001)
dehydrofelodipine is a metabolite of felodipine. Felodipine is a calcium channel blocker (calcium antagonist), a drug used to control hypertension (high blood pressure). It is marketed under the brand name Plendil by AstraZeneca and Renedil by Sanofi-Aventis. The formulation patent for the substance expired in 2007. AstraZeneca dropped Plendil from its support and AZ&Me free Rx access program in October 2008. (Wikipedia)
Cimicoxib
C16H13ClFN3O3S (381.03501500000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid
C18H17Cl2NO4 (381.0534582000001)
(+)-(6R,8S)-1-thiomethyldiscorhabdin G*/I trifluoroacetate
PRZ_M382
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2012
N-Acetylgalactosamine 4,6-disulfate
C8H15NO12S2 (381.00356700000003)
(CYANOMETHYL)TRIPHENYLPHOSPHONIUM BROMIDE
C20H17BrNP (381.02819120000004)
O,O-Diethylthiophosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate
4-(4-chlorophenylmethyl)-6,7-dimethoxy-isoquinoline methanesulfonate (1:1)
NXY-059
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant D002317 - Cardiovascular Agents
Platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane
C8H18OPtSi2 (381.05439879999994)
Mebutizide
C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
5-[(4-acetylbenzoyl)amino]-2-ethoxybenzenesulfonyl chloride
(6R,7R)-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C15H15N3O7S (381.06306800000004)
[5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazin-6-yl]methanol
2-amino-5-formylamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one
((2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-nitrophenoxy)tetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate
2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid
C18H17Cl2NO4 (381.0534582000001)
(5Z)-5-(3-Bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydro[1,2,4]triazolo[1,5-A]pyrimidin-7-amine
N-(hydroxymethyl)-N-{propyl[2-(2,4,6-trichlorophenoxy)ethyl]carbamoyl}methanimidamide
(4S)-2-acetyl-3,4,8,10,11,12-hexahydroxy-1,4-dihydrotetracen-1-one
[4,5-Dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate
2-acetamido-2-deoxy-4,6-di-O-sulfo-beta-D-galactopyranose
C8H15NO12S2 (381.00356700000003)
[(1S)-2-[2-[(2R)-2-amino-2-carboxyethyl]seleninyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium
2-[[[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxy-hydroxyphosphoryl]methylamino]acetic acid
N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamide
N-[[3-chloro-4-(4-morpholinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide
C16H16ClN3O2S2 (381.03724259999996)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-dibenzofuransulfonamide
C20H15NO5S (381.06709000000006)
4,5-Dichloro-2-[2-[2,5-dimethyl-1-(2,2,2-trifluoroethyl)-3-pyrrolyl]-2-oxoethyl]-3-pyridazinone
5-(1,3-benzodioxol-5-yl)-3-phenyl-2-sulfanylidene-4H-thiazolo[4,5-d]pyrimidin-7-one
C18H11N3O3S2 (381.02418159999996)
4-[[(3,6-Dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl ester
C18H17Cl2NO4 (381.0534582000001)
(E)-2-methylsulfonyl-3-[1-(4-nitrophenyl)sulfonylpyrrol-2-yl]prop-2-enenitrile
6-(Bromomethyl)-1,3-dimethyl-5-[(4-nitrophenyl)-oxomethyl]pyrimidine-2,4-dione
3-chloro-6-ethyl-N-(1H-indol-3-ylmethylene)-1-benzothiophene-2-carbohydrazide
C20H16ClN3OS (381.07025560000005)
2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid [2-(2,5-dichloroanilino)-2-oxoethyl] ester
C17H13Cl2NO5 (381.01707480000005)
2-(7-Bromo-1-methyl-5-triazolo[4,5-c]pyridin-5-iumyl)-1-(2-naphthalenyl)ethanone
N-{5-bromo-1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indol-3-yl}acetamide
4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzoic acid
4-chloro-N-[(2S)-5-hydroxy-2-methyl-2,3-dihydroindol-1-yl]-3-sulfamoylbenzamide
N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxotetrazol-1-yl]phenyl]ethanesulfonamide
Cimicoxib
C16H13ClFN3O3S (381.03501500000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
Desacetycefapirin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
5-bromo-1-[(1s)-2-methanesulfinyl-1-(methylamino)ethyl]-9h-pyrido[3,4-b]indol-6-ol
C15H16BrN3O2S (381.01465360000003)
5-bromo-1-[(1s)-2-[(r)-methanesulfinyl]-1-(methylamino)ethyl]-9h-pyrido[3,4-b]indol-6-ol
C15H16BrN3O2S (381.01465360000003)